Statin type and survival of patients with metastatic castrate-resistant prostate cancer receiving abiraterone and enzalutamide: A nationwide retrospective cohort study
Abstract only 50 Background: Studies have suggested that statin use is associated with prostate cancer mortality. However, uncertainties exist in how the solubility profile of statins impact cancer outcomes. Lipophilic statins have greater accessibility in extrahepatic tissues, which may lead to str...
Saved in:
Published in | Journal of clinical oncology Vol. 40; no. 6_suppl; p. 50 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
20.02.2022
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!